|4Jan 13, 5:24 PM ET

Claypoole Robert E 4

4 · Bioventus Inc. · Filed Jan 13, 2025

Insider Transaction Report

Form 4
Period: 2025-01-10
Claypoole Robert E
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-01-10+93,75093,750 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-01-1093,750281,250 total
    Class A Common Stock (93,750 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  • [F2]The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT